Characterization of antibodies in single-chain format against the E7 oncoprotein of the Human papillomavirus type 16 and their improvement by mutagenesis

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Donà, Maria Gabriella ^a   Giorgi, Colomba ^a   Accardi, Luisa ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINO ACID; PROTEIN ANTIBODY; PROTEIN E7;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DATA BASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EUKARYOTE; HUMAN PAPILLOMAVIRUS TYPE 16; IN VIVO STUDY; NONHUMAN; PHAGE DISPLAY; PLASMID; PROKARYOTE; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; TEMPERATURE; THERMOSTABILITY; UTERINE CERVIX CANCER;

ANTIBODIES, VIRAL; CELL LINE, TUMOR; DRUG STABILITY; ESCHERICHIA COLI; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOGLOBULIN FRAGMENTS; MUTAGENESIS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PEPTIDE LIBRARY; SOLUBILITY;

EID: 33847226329     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-25     Document Type: Article

References (33)

1. Bosch FX de Sanjosé S Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality J Natl Cancer Inst Monogr 2003 31 3 12807939
2. Munoz N Bosch FX de Sanjose S Herrero R Castellsague X Shah KV Snijders PJ Meijer CJ International Agency for Research on Cancer Multicenter Cervical Cancer Study Group Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 2003 348: 518 10.1056/NEJMoa021641 12571259
3. Eiben GL da Silva DM Fausch SC Le Poole IC Nishimura MI Kast WM Cervical cancer vaccines: Recent advances in HPV research Viral Immunol 2003 16 111 10.1089/088282403322017866 12828864
4. Munger K Basile JR Duensing S Eichten A Gonzalez SL Grace M Zacny VL Biological activities and molecular targets of the human papillomavirus E7 oncoprotein Oncogene 2001 20 7888 10.1038/sj.onc.1204860 11753671
5. zur Hausen H Papillomaviruses and cancer: From basic studies to clinical application Nat Rev Cancer 2002 2 342 Review 10.1038/nrc798 12044010
6. Balsitis SJ Sage J Duensing S Munger K Jacks T Lambert PF Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo Mol Cell Biol 2003 23 9094 309665 14645521 10.1128/ MCB.23.24.9094-9103.2003
7. Cornelison TL Human papillomavirus genotype 16 vaccines for cervical cancer prophylaxis and treatment Curr Opin Oncol 2000 12 466 10.1097/ 00001622-200009000-00014 10975555
8. Cardinale A Lener M Messina S Cattaneo A Biocca S The mode of action of Y13-259 scFv fragment intracellularly expressed in mammalian cells FEBS Lett 1998 439 197 10.1016/S0014-5793(98)01369-6 9845322
9. Lener M Horn IR Cardinale A Messina S Nielsen UB Rybak SM Hoogenboom HR Cattaneo A Biocca S Diverting a protein from its cellular location by intracellular antibodies. The case of p21Ras Eur J Biochem 2000 267 1196 10.1046/j.1432-1327.2000.01125.x 10672031
10. Holliger P Hudson PJ Engineered antibody fragments and the rise of single domains Nature Biotechnology 2005 23 1126 10.1038/nbt1142 16151406
11. Cardinale A Filesi I Vetrugno V Pocchiari M Sy MS Biocca S Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation J Biol Chem 2005 280 685 15513919
12. Worn A Pluckthun A Stability engineering of antibody Single-chain Fv fragments J Mol Biol 2001 305 989 10.1006/jmbi.2000.4265 11162109
13. Sibler AP Nordhammer A Masson M Martineau P Trave G Weiss E Nucleocytoplasmic shuttling of antigen in mammalian cells conferred by a soluble versus insoluble single-chain antibody fragment equipped with import/export signals Exp Cell Res 2003 286 276 10.1016/ S0014-4827(03)00093-4 12749856
14. Sibler AP Courtete J Muller CD Zeder-Lutz G Weiss E Extended half-life upon binding of destabilized intrabodies allows specific detection of antigen in mammalian cells FEBS J 2005 272 2878 10.1111/ j.1742-4658.2005.04709.x 15943819
15. Willuda J Honegger A Waibel R Schubiger PA Stahel R Zangemeister-Wittke U Pluckthun A High thermal stability is essential for tumor targeting of antibody fragments: Engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment Cancer Res 1999 59 5758 10582696
16. Jain RK Determinants of tumor blood flow: A review Cancer Res 1988 48 2641 Review 3282647
17. Pini A Viti F Santucci A Carnemolla B Zardi L Neri P Neri D Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel J Biol Chem 1998 273 21769 10.1074/jbc.273.34.21769 9705314
18. Accardi L Dona MG Di Bonito P Giorgi C Intracellular anti-E7 human antibodies in single-chain format inhibit proliferation of HPV16-positive cervical carcinoma cells Int J Cancer 2005 116 564 10.1002/ijc.21052 15818614
19. Zhu Q Zeng C Huhalov A Yao J Turi TG Danley D Hynes T Cong Y DiMattia D Kennedy S Daumy G Schaeffer E Marasco WA Huston JS Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7 J Immunol Methods 1999 231 207 10.1016/S0022-1759(99)00158-1 10648939
20. Visintin M Settanni G Maritan A Graziosi S Marks JD Cattaneo A The intracellular antibody capture technology (IACT): Towards a consensus sequence for intracellular antibodies J Mol Biol 2002 317 73 10.1006/ jmbi.2002.5392 11916379
21. Visintin M Quondam M Cattaneo A The intracellular antibody capture technology: Towards the high-throughput selection of functional intracellular antibodies for target validation Methods 2004 34 200 Review 10.1016/j.ymeth.2004.04.008 15312673
22. Sandee D Tungpradabkul S Kurokawa Y Fukui K Takagi M Combination of Dsb coexpression and an addition of sorbitol markedly enhanced soluble expression of single-chain Fv in Escherichia coli Biotechnol Bioeng 2005 91 418 10.1002/bit.20524 15937881
23. Lu D Jimenez X Witte L Zhu Z The effect of variable domain orientation and arrangement on the antigen-binding activity of a recombinant human bispecific diabody Biochem Biophys Res Commun 2004 318 507 10.1016/ j.bbrc.2004.04.060 15120630
24. Hugo N Weidenhaupt M Beukes M Xu B Janson JC Vernet T Altschuh D VL position 34 is a key determinant for the engineering of stable antibodies with fast dissociation rates Protein Eng 2003 16 381 10.1093/ protein/gzg042 12826730
25. Kabat EA Wu TT Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites J Immunol 1991 147 1709 1908882
26. Chothia C Gelfand I Kister A Structural determinants in the sequences of Immunoglobulin Variable Domain J Mol Biol 1998 278 457 10.1006/ jmbi.1998.1653 9571064
27. Persic L Righi M Roberts A Hoogenboom HR Cattaneo A Bradbury A Targeting vectors for intracellular immunisation Gene 1997 187 1 10.1016/ S0378-1119(96)00627-0 9073060
28. Persic L Roberts A Wilton J Cattaneo A Bradbury A Hoogenboom HR An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries Gene 1997 187 9 10.1016/S0378-1119(96)00628-2 9073061
29. Martineau P Betton JM In vitro folding and thermodynamic stability of an antibody fragment selected in vivo for high expression levels in Escherichia coli cytoplasm J Mol Biol 1999 292 921 10.1006/ jmbi.1999.3105 10525415
30. Tramontano A Chothia C Lesk AM Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins J Mol Biol 1990 215 175 10.1016/S0022-2836(05)80102-0 2118959
31. Ewert S Honegger A Pluckthun A Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering Methods 2004 34 184 10.1016/j.ymeth.2004.04.007 15312672
32. Ewert S Honegger A Pluckthun A Structure-based improvement of the biophysical properties of immunoglobulin VH domains with a generalizable approach Biochemistry 2003 42 1517 10.1021/bi026448p 12578364
33. Ewert S Huber T Honegger A Pluckthun A Biophysical properties of human antibody variable domains J Mol Biol 2003 325 531 10.1016/ S0022-2836(02)01237-8 12498801